(Q44661519)

5 December 2017

Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis (English)

1 reference

5 December 2017

Goldberg SV

1

1 reference

5 December 2017

Duchin JS

series ordinal

2

1 reference

5 December 2017

Shields T

series ordinal

3

1 reference

5 December 2017

Nolan CM

series ordinal

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

American Journal of Respiratory and Critical Care Medicine

5 December 2017

1 reference

5 December 2017

160

1 reference

5 December 2017

2

1 reference

5 December 2017

508-512

1 reference

Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy

5 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.2.9808039

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.2.9808039

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.2.9808039

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.2.9808039

Overseas screening for tuberculosis in immigrants and refugees to the United States: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.2.9808039

Tuberculosis prevention among foreign-born persons in Seattle--King County, Washington

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.2.9808039

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.2.9808039

A Controlled Trial of 3-Month, 4-Month, and 6-Month Regimens of Chemotherapy for Sputum-smear-negative Pulmonary Tuberculosis: Results at 5 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.2.9808039

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.2.9808039

10.1164/AJRCCM.160.2.9808039

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference